
    
      DICE regimen was found to be highly effective as induction chemotherapy in patients with
      early stage NK/T-cell lymphoma in the ongoing study. L-asparaginase, an agent with unique
      anti-cancer mechanism, was also found to be effective in salvage setting. In terms of
      non-overlapped efficacy and toxicity, the investigators designed this phase II study to
      verify the efficacy and tolerability of this new combination.
    
  